Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 603-607

  Cosyns, Mary ^a,d   Tsirkin, Svetlana ^a   Jones, Michelle ^a   Flavell, Richard ^b   Kikutani, Hitoshi ^c   Hayward, Anthony R ^a  

^a Univ of Colorado School of Medicine ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CHOLANGITIS; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; EPITHELIUM CELL; IMMUNE RESPONSE; INTESTINE EPITHELIUM; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; VIRUS CELL INTERACTION;

EID: 0031906464     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.603-607.1998     Document Type: Article

References (26)

1. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669-674.
2. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283-289.
3. + cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect. Immun. 61:3928-3932.
4. Chiu, J. H., C. P. Hu, W. Y. Lui, S. C. Lo, and C. M. Chang. 1990. The formation of bile canaliculi in human hepatoma cell lines. Hepatology 11:834-842.
5. Forbes, A., C. Blanshard, and B. Gazzard. 1993. Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut 34:116-121.
6. Goodgame, R. W. 1996 Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann. Intern. Med. 124:429-441.
7. Grewal I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620.
8. Griffiths, J. K., R. Moore, S. Dooley, G. T. Keusch, and S. Tzipori. 1994. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect. Immun. 62:4506-4514.
9. Hayward, A. R., J. Levy F. Facchetti, L. Notarangela, H. D. Ochs, A. Etzioni, J. Y. Bonnefoy, M. Cosyns, and A. Weinberg. 1997. Cholangiopathy and tumors of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM (XHIM). J. Immunol. 158:977-983.
10. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med 183:159-167.
11. Kamanaka, M. P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281.
12. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178.
13. Lane, P., T. Brocker, S. Rubele, E. Padovan, A. Lanzavecchia, and F. Mc-Connell. 1993. Soluble CD40 ligand can replace the normal T-cell derived CD40 ligand signal to B cells in T dependent activation. J. Exp. Med. 177:1209.
14. McGowan, I. A. S. Hawkins, and I. V. Weller. 1993. The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS 7:349-354.
15. Mead, J. R., M. J. Arrowood, R. W. Sidwell, and M. C. Healey. 1991. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J. Infect. Dis. 163:1297-1304.
16. Notarangelo, L. D., M. Dust, and A. G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3:101-121.
17. + T cell functions. J. Exp. Med. 183:2209-2218.
18. Ruby, J., H. Bluethmann, M. Aguet, and I. A. Ramshaw. 1995. CD40 ligand has potent antiviral activity. Nat. Med. 1:437-441.
19. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-73.
20. Ungar, B. L., J. A. Burns, C. A. Quinn, and F. D. Finkelman. 1990. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect. Immun. 58:961-969.
21. Upton, S. J., M. Tilley, M. V. Nesterenko, and D. B. Brillhart. 1994. A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol. Lett. 118:45-49.
22. Urban, J. F., R. Fayer, S. Chen, W. Gause, M. K. Gately, and F. D. Finkelman. 1996. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156:263-268.
23. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620-623.
24. Vierling, J. M. 1992. Immunological disorders of the liver and bile duct. Gastroenterol. Clin. N. Am. 21:427-449.
25. Whitmire, J. K., M. K. Slifka, I. S. Grewal, R. A. Flavell, and R. Ahmed. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70:8375-8381.
26. Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis pneumonia in mice. J. Immunol. 155:3525-3529.